ClinicalTrials.gov
public full text
Public Domain
Ginkgo Biloba Prevention Trial in Older Individuals
This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional disability, reducing incidence of cardiovascular disease, and decreasing total mortality.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Polyphenols and Risk of Dementia#842913
- CBT for African Americans With Cognitive Impairment#829991
- Oral Health Intervention Pilot Study for Individuals With Memory Problems#906312
- Abstracts from the 12th Canadian Conference on Dementia : Across the Dementia Cognitive Continuum: Prevention, Precision Medicine, and Practice Implications; October 16–18, 2025; Calgary, Alberta#676404
- Abstracts from the 12th Canadian Conference on Dementia: Across the Dementia Cognitive Continuum: Prevention, Precision Medicine, and Practice Implications; October 16–18, 2025; Calgary, Alberta.#636180
Record · ID 884036
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive